Close
0
Inquiry Basket
Contact Us Follow us on
Hot Products

Custom 2′,4,4′,6′-Tetrahydroxychalcone 4′-O-β-D-Glucoside Production Service

Unlock the Full Potential of Flavonoid Biosynthesis

Are you currently facing significant challenges such as low regioselectivity in chemical glycosylation, poor water solubility of complex chalcone derivatives, or limited access to high-purity analytical standards? These hurdles often delay critical phases of drug development and functional ingredient verification. Our Systematic Chemoenzymatic approach provides a definitive solution. We help you obtain high-purity glycosylated chalcones. We achieve this through our advanced enzymatic biotransformation technology, specifically utilizing high-efficiency Chalcone 4'-O-Glucosyltransferase to ensure precise structural modifications.

Our service focuses on the precision manufacturing of 2',4,4',6'-tetrahydroxychalcone 4'-O-β-D-glucoside, a critical flavonoid intermediate often referred to in the context of Safflower yellow pigments. The target molecule, derived from the substrate 2',4,4',6'-tetrahydroxychalcone, possesses unique biological properties including enhanced water solubility and stability compared to its aglycone form. Producing this compound via traditional organic chemistry is notoriously difficult due to the presence of multiple hydroxyl groups at the 2', 4', 4, and 6' positions, which leads to poor regioselectivity and complex mixtures of isomers. Creative Biolabs overcomes this bottleneck by employing a highly specific biocatalytic system. By harnessing the natural selectivity of chalcone 4'-O-glucosyltransferase, we ensure the glucose moiety is attached exclusively at the 4'-position. This service is essential for researchers needing authentic standards for metabolic pathway elucidation, potential therapeutic candidates for anti-inflammatory studies, or stable natural pigments for cosmetic applications.

Fig. 1. Important pharmacological properties of chalcones. (OA Literature) Fig.1 The pharmacological properties of chalcones.1

Professional Solutions for Complex Challenges - Inquiry Now

Detailed Production Service: Enzymatic Synthesis Strategy

This section outlines the step-by-step methodology we employ to deliver high-purity 2',4,4',6'-tetrahydroxychalcone 4'-O-β-D-glucoside through our proprietary enzymatic platform.

Phase I

Starting Materials and System Setup

  • Solubility management: The precursor, 2',4,4',6'-tetrahydroxychalcone, acts as the acceptor molecule. Since the chalcone substrate is hydrophobic, we design a biphasic or co-solvent reaction system to maintain substrate solubility without denaturing the chalcone 4'-O-glucosyltransferase.
  • Donor supply: We introduce the glycosyl donor, UDP-glucose, in a stoichiometric excess. For larger scales, we integrate a cofactor regeneration system to continuously recycle UDP back into UDP-Glucose, significantly reducing raw material costs.
Phase II

Regioselective Bioconversion

The synthesis reaction is conducted in temperature-controlled bioreactors under strict pH regulation (typically pH 7.0 to 8.0).

  • Mechanism: The enzyme specifically transfers the glucosyl group from UDP-glucose to the hydroxyl group at the 4'-position of the 2',4,4',6'-tetrahydroxychalcone scaffold.
  • Process control: We monitor the conversion rate in real-time using HPLC. This ensures we stop the reaction at the point of maximum yield and prevent any non-specific hydrolysis.
Phase III

Purification and Product Isolation

  • Extraction: Once the bioconversion is complete, we isolate the final 2',4,4',6'-tetrahydroxychalcone 4'-O-β-D-glucoside. The reaction mixture is processed to remove the protein catalyst and any unreacted UDP.
  • Chromatography: We utilize preparative reverse-phase HPLC to separate the target 4'-O-glucoside from any remaining unreacted chalcone substrate. This step is critical for achieving the high purity required for analytical standards.
  • Final form: The purified fractions are pooled, lyophilized, and packaged as a stable powder ready for shipment.

Detailed 2',4,4',6'-tetrahydroxychalcone 4'-O-β-D-glucoside production process. (Creative Biolabs AI)

Application

  • Biosynthetic pathway research: As a key intermediate in the biosynthesis of flavonoids, it is frequently used to study the catalytic mechanisms of chalcone isomerase (CHI) and glucosyltransferase in plants, helping researchers understand the evolution of plant secondary metabolites.
  • Natural antioxidant development: This compound possesses multiple hydroxyl structures, exhibiting extremely strong free radical scavenging capabilities. In functional foods or health supplements, it is used as a natural antioxidant to prevent chronic diseases related to oxidative stress.
  • Food preservation: Due to its natural dual antibacterial and antioxidant properties, this compound is used as a novel biopreservative in food packaging or as an additive to extend the shelf life of easily oxidized foods.

Accelerate Your Discovery - Get a Free Quote Now

FAQs

Q1: What is the typical purity level of the final product?

A: Typically, the minimum purity for standard orders is 95%. However, thanks to our advanced purification protocols, we frequently achieve purities greater than 95%, which are suitable for project research and development.

Q2: Is this process scalable for pilot-scale production?

A: Absolutely. Our enzyme immobilization technology allows us to scale seamlessly. We can move from milligram-scale R&D batches to gram-scale or even kilogram-scale production runs efficiently without changing the fundamental process.

Q3: How does enzymatic synthesis compare to chemical synthesis for this compound?

A: Chemical synthesis requires complex protecting groups for the hydroxyls at the 2', 4, and 6' positions to specifically target the 4' position. This lowers the overall yield and increases the cost significantly. Our enzymatic method is naturally regioselective, requiring no protecting groups, resulting in a cleaner, greener, and more cost-effective process.

Customer Review

High Specificity
"Using Creative Biolabs' custom production service in our research has significantly facilitated our enzymatic kinetic studies. The regioselectivity was perfect, eliminating the isomer contamination we faced with other vendors. It saved us months of purification work."- Senior Scientist, Dr. E**a.

Scalability Success
"We needed to scale from milligrams to grams quickly for our animal trials. Creative Biolabs' bioconversion process was seamless. The improved water solubility of the final product has significantly improved our bioavailability assays."- Formulation Chemist, J**a.

Rapid Turnaround
"The analytical data provided was comprehensive and professional. Using Creative Biolabs' service in our metabolomics project allowed us to verify our putative peaks with confidence. Highly recommended for complex glycosylations."- Principal Investigator, Dr. S**h.

Extended Services

Glycosyl Functional Enzyme Development

Custom expression of other Glycosyltransferases or biosynthetic enzymes in various host systems.

Metabolite Profiling

Advanced LC-MS/MS analysis to map flavonoid pathways in your complex biological samples.

Custom Organic Synthesis

For non-natural derivatives or analogues that cannot be produced enzymatically.

Substrate Specificity Screening

High-throughput screening of your candidate enzymes against our extensive library of substrates.

How to Contact Us

Secure your supply of high-purity 2',4,4',6'-tetrahydroxychalcone 4'-O-β-D-glucoside with Creative Biolabs. We understand that precise regioselectivity and compound integrity are non-negotiable for your analytical standards and functional assays. Our dedicated technical team is ready to support your project from initial feasibility assessment to final delivery. Whether you require milligram quantities for target validation or gram-scale production for formulation development, our custom 2',4,4',6'-tetrahydroxychalcone 4'-O-β-D-glucoside production service offers the reliability and scientific rigor you demand. Please contact us to inquire about more details.

Reference

  1. Salehi, Bahare et al. "Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence." Frontiers in Pharmacology vol. 11 592654. 18 Jan. 2021. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fphar.2020.592654
For Research Use Only.

Related Services

Online Inquiry
Copyright © Creative Biolabs. All Rights Reserved.